loading...

COA Instruments Distributed by Mapi Research Trust

default distrib

ALS Survey / Amyotrophic Lateral Sclerosis Survey Amyotrophic Lateral Sclerosis Survey

Barohn RJ et al.

To assess symptoms and their impact on activities of daily living (ADL) in patients with Amyotrophic Lateral Sclerosis (ALS)

Therapeutic indications : Amyotrophic Lateral Sclerosis, Muscular Atrophy, Spinal, Motor Neuron Disease

default distrib

AOM-Diary / Acute Otitis Media Symptoms Diary Acute Otitis Media Symptoms Diary

Sanofi Aventis et al.

To capture data on the child’s daily level of Acute Otitis Media (AOM) symptom severity and to systematically assess resolution of symptoms

Therapeutic indications : Otitis Media

default distrib

AQLQ / Asthma Quality of Life Questionnaire Asthma Quality of Life Questionnaire

Juniper E et al.

To measure the functional impairments that are most troublesome to adults (17-70 years) as a result of their asthma

Therapeutic indications : Asthma

default distrib

AQLQ-M / Asthma Quality of Life Questionnaire - Marks Asthma Quality of Life Questionnaire - Marks

Marks GB, Dunn M, Woolcock AJ et al.

To measure the impact of asthma on quality of life

Therapeutic indications : Asthma

default distrib

ASAT / Addiction Severity Assessment Tool Addiction Severity Assessment Tool

Butler SF, McGee MD, Davis MS, Cornelli R, Morey LC, Budman SH et al.

Behavioral health adult screener that measures problem severity in daily functioning, relationships, dysphoric states, dependence severity, recovery skill/self-efficacy, and existential factors for substance abuse clients

Therapeutic indications : Substance-Related Disorders

default distrib

ASI / Addiction Severity Index Addiction Severity Index

McLellan AT, Luborsky L, Woody GE, O'Brien CP et al.

To produce a problem severity profile of each patient through an analysis of six general areas

Therapeutic indications : Substance-Related Disorders, Alcoholism

default distrib

ASK-12 / Adherence Starts with Knowledge 12 Adherence Starts with Knowledge 12

GlaxoSmithKline Research and Development Limited (GSK) et al.

To measure barriers to medication adherence and adherence-related behavior.

Therapeutic indications : All

default distrib

ASK-20 / Adherence Starts with Knowledge 20 Adherence Starts with Knowledge 20

GlaxoSmithKline Research and Development Limited (GSK) et al.

To measure barriers to medication adherence and adherence-related behavior

Therapeutic indications : All

default distrib

ASRS / Augmentation Severity Rating Scale Augmentation Severity Rating Scale

The European Restless Legs Syndrome Study Group (EURLSSG) et al.

To assess severity of augmentation, the main complication during long-term dopaminergic treatment of restless legs syndrome (RLS)

Therapeutic indications : Restless Legs Syndrome

default distrib

AUQUEI / Pictured Child’s Quality of Life Self Questionnaire Pictured Child’s Quality of Life Self Questionnaire

Dazord A, Manificat S et al.

To assess the child’s subjective Quality of Life

Therapeutic indications : All

default distrib

Barthel Index / Barthel Index Barthel Index

Mahoney FI, Barthel DW et al.

To measure a person's daily functioning specifically the activities of daily living (ADL) and mobility

Therapeutic indications : All

default distrib

BAS-G / Bath Ankylosing Spondylitis Global score Bath Ankylosing Spondylitis Global score

Jones SD, Steiner A, Garrett SL, Calin A et al.

To reflect the effect of ankylosing spondylitis (AS) on the patient's well-being

Therapeutic indications : Spondylitis, Ankylosing

default distrib

BASDAI / Bath Ankylosing Spondylitis Disease Activity Index Bath Ankylosing Spondylitis Disease Activity Index

Calin A et al.

To define disease activity in patients with ankylosing spondylitis

Therapeutic indications : Spondylitis, Ankylosing

default distrib

BASFI / Bath Ankylosing Spondylitis Functional Index Bath Ankylosing Spondylitis Functional Index

Calin A et al.

To define and monitor functional ability in patients with ankylosing spondylitis

Therapeutic indications : Spondylitis, Ankylosing

default distrib

BASMI / Bath Ankylosing Spondylitis Metrology Index Bath Ankylosing Spondylitis Metrology Index

Calin A et al.

To define clinically significant changes in spinal movement

Therapeutic indications : Spondylitis, Ankylosing

default distrib

BASRI-h / Bath Ankylosing Spondylitis Radiology Index - Hip Bath Ankylosing Spondylitis Radiology Index - Hip

Mackay K, Brophy S, Mack C, Calin A, Doran M, Santos H et al.

To grade hip radiological changes in patients with Ankylosing Spondylitis

Therapeutic indications : Spondylitis, Ankylosing

default distrib

BASRI-s / Bath Ankylosing Spondylitis Radiology Index - Spine Bath Ankylosing Spondylitis Radiology Index - Spine

Calin A, Mack C, Mackay K, Santos H, Brophy S et al.

To grade spin radiographic changes in patients with Ankylosing Spondylitis

Therapeutic indications : Spondylitis, Ankylosing

default distrib

BAT / Bladder Assessment Tool Bladder Assessment Tool

Astellas Pharma Europe Ltd et al.

To assess Overactive Bladder (OAB) symptoms, impact, bother, and treatment satisfaction

Therapeutic indications : Urinary Bladder, Overactive

default distrib

BDI-TDI / Baseline and Transition Dyspnea Indexes Baseline and Transition Dyspnea Indexes

Mahler DA et al.

To provide a multidimensional measurement of dyspnea based on activities of daily living in symptomatic individuals

Therapeutic indications : Asthma, Cystic Fibrosis, Pulmonary Disease, Chronic Obstructive

default distrib

BENS Score / Bowel Endometriosis Syndrome Score Bowel Endometriosis Syndrome Score

Riiskjær M, Egekvist AG, Hartwell D, Forman A, Seyer-Hansen M, Kesmodel US et al.

To identify women with BENS and to monitor the effect of medical and surgical treatment of women suffering from bowel endometriosis

Therapeutic indications : Endometriosis